Urinary excretion of L-carnitine, acetyl-L-carnitine, propionyl-L-carnitine and their antioxidant activities after single dose administration of L-carnitine in healthy subjects

The urine excretion of L-carnitine (LC), acetyl-L-carnitine (ALC) and propionyl-Lcarnitine (PLC) and their relations with the antioxidant activities are presently unknown. Liquid L-carnitine (2.0 g) was administered orally as a single dose in 12 healthy subjects. Urine concentrations of LC, ALC and PLC were detected by HPLC. Superoxide dismutase (SOD), total antioxidative capacity (T-AOC), malondialdehyde (MDA) and nitrogen monoxidum (NO) activities were measured by spectrophotometric methods. The 0~2 h, 2~4 h, 4~8 h, 8~12 h, 12~24 h excretion of LC was 53.13±31.36 µmol, 166.93±76.87 µmol, 219.92±76.30 µmol, 100.48±23.89 µmol, 72.07±25.77 µmol, respectively. The excretion of ALC was 29.70±14.43 µmol, 80.59±32.70 µmol, 109.85±49.21 µmol, 58.65±18.55 µmol, and 80.43±35.44 µmol, respectively. The urine concentration of PLC was 6.63±4.50 µmol, 15.33±12.59 µmol, 15.46±6.26 µmol, 13.41±11.66 µmol and 9.67±7.92 µmol, respectively. The accumulated excretion rate of LC was 6.1% within 24h after its administration. There was also an increase in urine concentrations of SOD and T-AOC, and a decrease in NO and MDA. A positive correlation was found between urine concentrations of LC and SOD (r = 0.8277) or T-AOC (r = 0.9547), and a negative correlation was found between urine LC excretions and NO (r = -0.8575) or MDA (r = 0.7085). In conclusion, a single oral LC administration let to a gradual increase in urine L-carnitine excretion which was associated with an increase in urine antioxidant enzymes and the total antioxidant capacities. These data may be useful in designing therapeutic regimens of LC or its analogues in the future.

Saved in:
Bibliographic Details
Main Authors: Cao,Yu, Hao,Chuan-ji, Wang,Chen-jing, Li,Peng-li, Wang,Le-xin, Guan,Hua-shi, Li,Huan-ting
Format: Digital revista
Language:English
Published: Universidade de São Paulo, Faculdade de Ciências Farmacêuticas 2013
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502013000100020
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1984-82502013000100020
record_format ojs
spelling oai:scielo:S1984-825020130001000202013-04-19Urinary excretion of L-carnitine, acetyl-L-carnitine, propionyl-L-carnitine and their antioxidant activities after single dose administration of L-carnitine in healthy subjectsCao,YuHao,Chuan-jiWang,Chen-jingLi,Peng-liWang,Le-xinGuan,Hua-shiLi,Huan-ting L-carnitine/antioxidant activity Acetyl-L-carnitine/antioxidant activity Propionyl-Lcarnitine/antioxidant activity Antioxidants Urine excretion/analysis The urine excretion of L-carnitine (LC), acetyl-L-carnitine (ALC) and propionyl-Lcarnitine (PLC) and their relations with the antioxidant activities are presently unknown. Liquid L-carnitine (2.0 g) was administered orally as a single dose in 12 healthy subjects. Urine concentrations of LC, ALC and PLC were detected by HPLC. Superoxide dismutase (SOD), total antioxidative capacity (T-AOC), malondialdehyde (MDA) and nitrogen monoxidum (NO) activities were measured by spectrophotometric methods. The 0~2 h, 2~4 h, 4~8 h, 8~12 h, 12~24 h excretion of LC was 53.13±31.36 µmol, 166.93±76.87 µmol, 219.92±76.30 µmol, 100.48±23.89 µmol, 72.07±25.77 µmol, respectively. The excretion of ALC was 29.70±14.43 µmol, 80.59±32.70 µmol, 109.85±49.21 µmol, 58.65±18.55 µmol, and 80.43±35.44 µmol, respectively. The urine concentration of PLC was 6.63±4.50 µmol, 15.33±12.59 µmol, 15.46±6.26 µmol, 13.41±11.66 µmol and 9.67±7.92 µmol, respectively. The accumulated excretion rate of LC was 6.1% within 24h after its administration. There was also an increase in urine concentrations of SOD and T-AOC, and a decrease in NO and MDA. A positive correlation was found between urine concentrations of LC and SOD (r = 0.8277) or T-AOC (r = 0.9547), and a negative correlation was found between urine LC excretions and NO (r = -0.8575) or MDA (r = 0.7085). In conclusion, a single oral LC administration let to a gradual increase in urine L-carnitine excretion which was associated with an increase in urine antioxidant enzymes and the total antioxidant capacities. These data may be useful in designing therapeutic regimens of LC or its analogues in the future.info:eu-repo/semantics/openAccessUniversidade de São Paulo, Faculdade de Ciências FarmacêuticasBrazilian Journal of Pharmaceutical Sciences v.49 n.1 20132013-03-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502013000100020en10.1590/S1984-82502013000100020
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Cao,Yu
Hao,Chuan-ji
Wang,Chen-jing
Li,Peng-li
Wang,Le-xin
Guan,Hua-shi
Li,Huan-ting
spellingShingle Cao,Yu
Hao,Chuan-ji
Wang,Chen-jing
Li,Peng-li
Wang,Le-xin
Guan,Hua-shi
Li,Huan-ting
Urinary excretion of L-carnitine, acetyl-L-carnitine, propionyl-L-carnitine and their antioxidant activities after single dose administration of L-carnitine in healthy subjects
author_facet Cao,Yu
Hao,Chuan-ji
Wang,Chen-jing
Li,Peng-li
Wang,Le-xin
Guan,Hua-shi
Li,Huan-ting
author_sort Cao,Yu
title Urinary excretion of L-carnitine, acetyl-L-carnitine, propionyl-L-carnitine and their antioxidant activities after single dose administration of L-carnitine in healthy subjects
title_short Urinary excretion of L-carnitine, acetyl-L-carnitine, propionyl-L-carnitine and their antioxidant activities after single dose administration of L-carnitine in healthy subjects
title_full Urinary excretion of L-carnitine, acetyl-L-carnitine, propionyl-L-carnitine and their antioxidant activities after single dose administration of L-carnitine in healthy subjects
title_fullStr Urinary excretion of L-carnitine, acetyl-L-carnitine, propionyl-L-carnitine and their antioxidant activities after single dose administration of L-carnitine in healthy subjects
title_full_unstemmed Urinary excretion of L-carnitine, acetyl-L-carnitine, propionyl-L-carnitine and their antioxidant activities after single dose administration of L-carnitine in healthy subjects
title_sort urinary excretion of l-carnitine, acetyl-l-carnitine, propionyl-l-carnitine and their antioxidant activities after single dose administration of l-carnitine in healthy subjects
description The urine excretion of L-carnitine (LC), acetyl-L-carnitine (ALC) and propionyl-Lcarnitine (PLC) and their relations with the antioxidant activities are presently unknown. Liquid L-carnitine (2.0 g) was administered orally as a single dose in 12 healthy subjects. Urine concentrations of LC, ALC and PLC were detected by HPLC. Superoxide dismutase (SOD), total antioxidative capacity (T-AOC), malondialdehyde (MDA) and nitrogen monoxidum (NO) activities were measured by spectrophotometric methods. The 0~2 h, 2~4 h, 4~8 h, 8~12 h, 12~24 h excretion of LC was 53.13±31.36 µmol, 166.93±76.87 µmol, 219.92±76.30 µmol, 100.48±23.89 µmol, 72.07±25.77 µmol, respectively. The excretion of ALC was 29.70±14.43 µmol, 80.59±32.70 µmol, 109.85±49.21 µmol, 58.65±18.55 µmol, and 80.43±35.44 µmol, respectively. The urine concentration of PLC was 6.63±4.50 µmol, 15.33±12.59 µmol, 15.46±6.26 µmol, 13.41±11.66 µmol and 9.67±7.92 µmol, respectively. The accumulated excretion rate of LC was 6.1% within 24h after its administration. There was also an increase in urine concentrations of SOD and T-AOC, and a decrease in NO and MDA. A positive correlation was found between urine concentrations of LC and SOD (r = 0.8277) or T-AOC (r = 0.9547), and a negative correlation was found between urine LC excretions and NO (r = -0.8575) or MDA (r = 0.7085). In conclusion, a single oral LC administration let to a gradual increase in urine L-carnitine excretion which was associated with an increase in urine antioxidant enzymes and the total antioxidant capacities. These data may be useful in designing therapeutic regimens of LC or its analogues in the future.
publisher Universidade de São Paulo, Faculdade de Ciências Farmacêuticas
publishDate 2013
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502013000100020
work_keys_str_mv AT caoyu urinaryexcretionoflcarnitineacetyllcarnitinepropionyllcarnitineandtheirantioxidantactivitiesaftersingledoseadministrationoflcarnitineinhealthysubjects
AT haochuanji urinaryexcretionoflcarnitineacetyllcarnitinepropionyllcarnitineandtheirantioxidantactivitiesaftersingledoseadministrationoflcarnitineinhealthysubjects
AT wangchenjing urinaryexcretionoflcarnitineacetyllcarnitinepropionyllcarnitineandtheirantioxidantactivitiesaftersingledoseadministrationoflcarnitineinhealthysubjects
AT lipengli urinaryexcretionoflcarnitineacetyllcarnitinepropionyllcarnitineandtheirantioxidantactivitiesaftersingledoseadministrationoflcarnitineinhealthysubjects
AT wanglexin urinaryexcretionoflcarnitineacetyllcarnitinepropionyllcarnitineandtheirantioxidantactivitiesaftersingledoseadministrationoflcarnitineinhealthysubjects
AT guanhuashi urinaryexcretionoflcarnitineacetyllcarnitinepropionyllcarnitineandtheirantioxidantactivitiesaftersingledoseadministrationoflcarnitineinhealthysubjects
AT lihuanting urinaryexcretionoflcarnitineacetyllcarnitinepropionyllcarnitineandtheirantioxidantactivitiesaftersingledoseadministrationoflcarnitineinhealthysubjects
_version_ 1756437759627624448